These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 19148507

  • 1. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K, Kohnoe S, Watanabe A, Tashiro H, Sakata H, Morita M, Kakeji Y, Maehara Y.
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    J Clin Oncol; 2005 Jan 20; 23(3):448-54. PubMed ID: 15572731
    [Abstract] [Full Text] [Related]

  • 3. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
    Endo K, Kohnoe S, Tsujita E, Watanabe A, Nakashima H, Baba H, Maehara Y.
    Anticancer Res; 2005 Jan 20; 25(4):3117-21. PubMed ID: 16080575
    [Abstract] [Full Text] [Related]

  • 4. Disturbed XIAP and XAF1 expression balance is an independent prognostic factor in gastric adenocarcinomas.
    Shibata T, Noguchi T, Takeno S, Gabbert HE, Ramp U, Kawahara K.
    Ann Surg Oncol; 2008 Dec 20; 15(12):3579-87. PubMed ID: 18807090
    [Abstract] [Full Text] [Related]

  • 5. Immunoexpression of inhibitors of apoptosis proteins and their antagonist SMAC/DIABLO in colorectal carcinoma: correlation with apoptotic index, cellular proliferation and prognosis.
    De Oliveira Lima F, De Oliveira Costa H, Barrezueta LF, Fujiyama Oshima CT, Silva JA, Gomes TS, Pinheiro N, Neto RA, Franco M.
    Oncol Rep; 2009 Aug 20; 22(2):295-303. PubMed ID: 19578769
    [Abstract] [Full Text] [Related]

  • 6. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST, Gui SQ, Lin MS.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 20; 5(4):580-3. PubMed ID: 17085346
    [Abstract] [Full Text] [Related]

  • 7. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM, Zhu ZH, Wu QL, Hou JH, Huang XP, Zhang PY, Rong TH.
    Ai Zheng; 2006 May 20; 25(5):631-4. PubMed ID: 16687088
    [Abstract] [Full Text] [Related]

  • 8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
    Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A.
    Clin Cancer Res; 2008 Jan 01; 14(1):143-8. PubMed ID: 18172264
    [Abstract] [Full Text] [Related]

  • 9. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ.
    Ann Surg Oncol; 2009 Feb 01; 16(2):297-303. PubMed ID: 19050975
    [Abstract] [Full Text] [Related]

  • 10. Role of Smac/DIABLO in cancer progression.
    Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J.
    J Exp Clin Cancer Res; 2008 Sep 26; 27(1):48. PubMed ID: 18822137
    [Abstract] [Full Text] [Related]

  • 11. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
    Paik SS, Jang KS, Song YS, Jang SH, Min KW, Han HX, Na W, Lee KH, Choi D, Jang SJ.
    Ann Surg Oncol; 2007 Dec 26; 14(12):3453-9. PubMed ID: 17882496
    [Abstract] [Full Text] [Related]

  • 12. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
    Huh JW, Kim HR, Kim YJ, Lee JH, Park YS, Cho SH, Joo JK.
    Pathol Int; 2009 Apr 26; 59(4):241-6. PubMed ID: 19351367
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
    Ann Surg Oncol; 2008 May 26; 15(5):1530-7. PubMed ID: 18259822
    [Abstract] [Full Text] [Related]

  • 14. Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas.
    Ren Y, Akyurek N, Schlette E, Rassidakis GZ, Medeiros LJ.
    Hum Pathol; 2006 Nov 26; 37(11):1407-13. PubMed ID: 16949641
    [Abstract] [Full Text] [Related]

  • 15. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.
    Oncology; 2009 Nov 26; 77(1):53-62. PubMed ID: 19556810
    [Abstract] [Full Text] [Related]

  • 16. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB, Wu AG, Chen YJ, Tang BH.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec 26; 25(12):1524-8. PubMed ID: 16361154
    [Abstract] [Full Text] [Related]

  • 17. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
    Deng YJ, Tang N, Liu C, Zhang JY, An SL, Peng YL, Ma LL, Li GQ, Jiang Q, Hu CT, Wang YN, Liang YZ, Bian XW, Fang WG, Ding YQ.
    Clin Cancer Res; 2014 Jul 15; 20(14):3809-17. PubMed ID: 24916695
    [Abstract] [Full Text] [Related]

  • 18. Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas.
    Tanimoto T, Tsuda H, Imazeki N, Ohno Y, Imoto I, Inazawa J, Matsubara O.
    Cancer Lett; 2005 Jun 16; 224(1):141-51. PubMed ID: 15911110
    [Abstract] [Full Text] [Related]

  • 19. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
    Hatate K, Yamashita K, Hirai K, Kumamoto H, Sato T, Ozawa H, Nakamura T, Onozato W, Kokuba Y, Ihara A, Watanabe M.
    Oncol Rep; 2008 Oct 16; 20(4):737-43. PubMed ID: 18813812
    [Abstract] [Full Text] [Related]

  • 20. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A.
    Cancer; 2008 Feb 01; 112(3):495-502. PubMed ID: 18076013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.